Viewing Study NCT00913133


Ignite Creation Date: 2025-12-25 @ 3:08 AM
Ignite Modification Date: 2026-03-06 @ 1:27 AM
Study NCT ID: NCT00913133
Status: COMPLETED
Last Update Posted: 2013-01-10
First Post: 2009-05-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis
Sponsor: Canyon Pharmaceuticals, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Thrombosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anticoagulation View
None Prophylaxis View
None Desirudin View
None Direct thrombin inhibitor View
None Heparin-induced thrombocytopenia View